2023 Speakers

Joycelyn Lee

Consultant | Singapore

Dr Lee is a medical oncologist in the Department of Gastrointestinal Oncology, Division of Medical Oncology at National Cancer Centre Singapore. She sees patients and conducts clinical research in the field of gastrointestinal oncology, with an interest in hepatopancreatobiliary cancers, immuno-oncology and supportive care. She participates in postgraduate and undergraduate medical teaching.

Keefe Lai

Consultant | Singapore

Dr Keefe Lai is a Consultant with the Department of Diagnostic Radiology at Singapore General Hospital. He completed his medical degree at the National University of Singapore, Yong Loo Lin School of Medicine in 2011. He obtained the Fellowship of the Royal College of Radiologists in 2016 and completed his specialty training under the SingHealth Diagnostic Radiology Residency Program in 2019. He obtained the Certified Imaging Informatics Professional in 2019. He currently practices chest, abdomen and pelvic imaging and is also the Deputy Director of Imaging Informatics in the Division of Radiological Sciences, Singapore General Hospital. His clinical subspecialisation focus is colorectal imaging, particularly of rectal cancer. His administrative, educational and research interests are operational resilience in the context of an ageing population, medical perception, and CT Biomarkers for opportunistic health screening and predictive modelling of health outcomes respectively.

Ang Soo Fan

Senior Consultant Medical Oncologist | Malaysia

Dr Ang Soo Fan is a senior consultant medical oncologist at the National Cancer Centre Singapore. He is currently a visiting consultant medical oncologist at the Penang Adventist Hospital, Malaysia. Dr Ang graduated from the University of Malaya in 2001. He obtained his membership of the Royal College of Physicians (United Kingdom) and subsequently practiced as a Medical Specialist in the Department of Internal Medicine at Klang General Hospital. He underwent advanced specialty training in medical oncology at the National Cancer Centre Singapore (NCCS), and subsequently practiced as a consultant medical oncologist at NCCS. In addition to general medical oncology, Dr Ang has keen interest in gastrointestinal cancer and liver cancer. Dr Ang is actively involved with multiple international phase III clinical trials, and is also a reviewer of several peered-review journals. He has been actively involved in teaching for oncology trainee and nurses, and also a speaker for many local and international meetings.

Apoorva Gogna

Senior Consultant Interventional Radiologist | Singapore

Dr Apoorva is Senior Consultant Interventional Radiologist in Singapore General Hospital Department of Vascular and Interventional Radiology, Clinical Associate Professor in Duke-NUS Medical School and Visiting Consultant in several public health institutes. His main interests are in diagnosis and minimally invasive treatments of cancers, vascular, lymphatic and urogenital disorders. He is principal investigator or co-investigator in several clinical trials and serves as Director for Intervention and Medical Devices Research in SingHealth Academic Clinical Programme.

Arndt Vogel

Medical Oncologist | Canada

Prof. Arndt Vogel, MD, is managing senior consultant and professor in the Department of Gastroenterology, Hepatology and Endocrinology at Hannover Medical School. He is head of the GI-Cancer Center and of the Center for Personalized Medicine at Medical School Hannover. Prof Vogel’s scientific focus is the translational and clinical research in GI cancers and he is leading a basic research group interested in the pathogenesis of GI-cancers with a special focus on hepatobiliary cancers and precision medicine.

Bhawna Sirohi

Medical Director | India

Dr. Bhawna Sirohi started her oncology career at Tata Memorial centre (TMC), Mumbai in 1994 and completed training at Royal Marsden NHS Foundation Trust, UK. She serves in BALCO Medical Centre as a Medical Director and is currently an honorary consultant with QMUL, London. At TMC in 2012-2014, she set up GI medical oncology &medical oncology information system (MOIS) for e-prescribing chemotherapy. She has been involved in initial setting up of cancer centres in Sangrur and Mohali, Punjab for TMC. She has piloted use of virtual consults using PROM & PREM in London.

Brigette Ma

Professor and Honorary Consultant at the Department of Clinical Oncology | Hong Kong

Dr Brigette Ma is currently Professor and Honorary Consultant at the Department of Clinical Oncology, Chinese University of Hong Kong, and Honorary Professor, Department of Health Technology and Informatics, The Hong Kong Polytechnic University. She is also the Medical Director of the Phase I Clinical Trial Centre (Oncology) and Co-Director of the Cancer Drug Testing Unit at the Department of Clinical Oncology, Prince of Wales Hospital, Chinese University of Hong Kong. She is the Vice-President of the Hong Kong Nasopharyngeal Cancer Study Group and President of the Hong Kong Head and Neck Society. Dr Ma is a member of European Society of Medical Oncology (ESMO) Consensus Working Group for the management of metastatic colorectal cancer, a member of the International Advisory Board of the Lancet Oncology, and serves in the editorial board of the Asian-Pacific Journal of Clinical Oncology.

Chee Cheng Ean

Consultant Medical Oncologist | Singapore

Dr. Chee is a clinician-investigator and medical oncologist in gastrointestinal and hepatobiliary cancers in NCIS. As the Programme Director for the NUHS Medical Oncology Senior Residency [Fellowship] Programme, she is actively involved in the education of the Medical Oncology trainees and she also chairs the Colorectal Cancer Committee of the Singapore Cancer Society

Chiun Hsu

Professor and Chairman of Department of Surgery | Taiwan

Chiun-Sheng Huang is the professor and chairman of Department of Surgery at the National Taiwan University Hospital and National Taiwan University College of Medicine. He is also the director of Breast Care Center at the National Taiwan University Hospital, Taipei, Taiwan. Dr Huang has dedicated his career to the prevention and treatment of breast cancer. His areas of research include: ultrasound in breast cancer screening and axillary staging; computer-aided diagnosis and detection of breast ultrasound; single nucleotide polymorphism and circulating tumor DNA as susceptibility and prognostic factor for breast cancer; and development of new regimens and biomarkers using neoadjuvant therapy.

Emile Tan

Head ＆ Senior Consultant | Singapore

Emile read Medicine at the University College London Medical School before completing both his basic and higher surgical training in London. He completed a year-long fellowship at the Royal Marsden Hospital, London Along the way, he helped to set up a pelvic floor translational research platform on behalf of Imperial College London, and took the opportunity to develop his career as a clinical academic. He was awarded a National Institute for Health (NIHR UK) Academic Clinical Fellowship in 2008, followed by an NIHR award for a Clinical Academic Lectureship in 2011. Emile has published widely in international peer-reviewed journals, and presented internationally. He maintains a strong interest in minimally invasive and open cancer surgery, and pelvic floor disease, in particular laparoscopic prolapse and functional surgery, as well as neuromodulation.

Faye Lim

Senior Consultant | Singapore

Dr Faye Lim graduated from the University of Nottingham Medical school and completed her Clinical Oncology Training at Mount Vernon Cancer Centre and University College Hospital. She is a senior consultant in the department of radiation oncology at the National Cancer Centre Singapore Her sub specialty includes breast and gastrointestinal cancers. She has a particular interest in the use of proton therapy in the treatment of breast cancer.

Francis Ho

Adjunct Associate Professor Medicine | Singapore

Adjunct Associate Professor Francis Ho is a Senior Consultant in the National University Cancer Institute, Singapore (NCIS), where he heads the Department of Radiation Oncology which provides radiotherapy services to the NUHS and NHG cluster; and serves as the Lead for the Geriatric Oncology Service in NCIS. He completed his medical training with the Faculty of Medicine, National University of Singapore (NUS) in 2002 and was then appointed as a Fellow of the Royal Australian and New Zealand College of Radiologists, as well as a Fellow of the Academy of Medicine, Singapore (FAMS) in 2012.

Han Shuting

Consultant Medical Oncologist | Singapore

Dr. Han Shuting is a Consultant Medical Oncologist at the National Cancer Centre Singapore (NCCS). She graduated with Bachelor of Arts (Honours) from Christ’s College, Cambridge in 2010 and Bachelor of Medicine and Surgery (MBBChir) from Cambridge School of Clinical Medicine in 2013. Subsequently, she obtained her MRCP (UK) and MMed (Int. Med) accreditation in 2015. She completed her medical oncology training in NCCS in 2019. She is currently pursuing a PhD at the National University of Singapore under the National Medical Research Council (NMRC) research training fellowship award. She sub-specialises in gastrointestinal cancers and her areas of research include colorectal cancers, viral-driven cancers and immuno-oncology.

Ho Gwo Fuang

Professor and Clinical Oncologist | Malaysia

Dr Ho Gwo Fuang is a Professor and clinical oncologist at University Malaya Medical Centre and University Malaya Specialist Centre, Kuala Lumpur, Malaysia. He was trained at Barts and The London National Health Service (NHS) Trust and The Royal Marsden NHS Trust in London. He attained his Certificate for Completion of Specialist Training (CCST) in 2007 and joined the Faculty of Medicine at University Malaya. He was the recipient of the Joint Commission International (JCI) Outstanding Young Malaysian Award in 2009 for medical innovation. His research interests involve breast, gastrointestinal and gynaecological cancers. He is involved in many national and international collaborative research work, as well as the training of new oncologists in Malaysia.

Iain Tan

Medical Oncologist | Singapore

Dr. Iain Tan is a Senior Consultant Medical Oncologist, leading the colorectal cancer service in the GI Oncology Team at the Department of Medical Oncology, National Cancer Centre Singapore. Dr Iain Tan, a clinician-scientist at A*STAR’s Genome Institute of Singapore (GIS), was awarded the prestigious Singapore Youth Award 2014. Dr Tan has been recognized for his contributions as a consultant oncologist at the National Cancer Singapore (NCCS) and research scientist at GIS, and for his efforts to cultivate an environment conducive for translational research. Dr Tan’s research focuses on new ways in the early detection and diagnosis of colorectal cancer.

Jens Samol

Senior Consultant Medical Oncologist | Singapore

Skilled in Clinical Research, Medical Education, Life Sciences, Haemato-Oncology, and Medicine. Strong healthcare professional focused on Medical Oncology including Haemato-Oncology, medical education and clinical research. Senior Consultant Medical Oncologist at Tan Tock Seng Hospital. Director, Clinical Trials, CRIO & Co-Director (TTSH) PHFRC. Adj/Asst Prof at LKC School of Medicine. Asst Professor of Oncology Johns Hopkins University. His clinical interests include Thoracic Cancers, Gastrointestinal Cancers, Head & Neck Cancers, HIPEC, Sarcomas, Genitourinary Cancers, and Lymphomas. Cancer Genetics and Clinical Research Trials.

Joan Choo

Medical Oncologist | Singapore

Dr. Joan Choo is a Medical Oncologist based at National University Hospital in Queenstown, Singapore.

Johnny Ong

Senior Consultant | Singapore

Dr Johnny Ong is a Senior Consultant in the Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, National Cancer Centre Singapore. He is also the Principal Investigator of the Laboratory of Applied Human Genetics, NCCS. Dr Ong is currently one of the only formally trained surgeons for sarcoma in Singapore. He is one of the key opinion leaders in the field of sarcoma and seeks to advance the care of sarcoma in Singapore and Asia Pacific.

Justina Lam

Consultant | Singapore

Dr Justina Lam graduated with MBBS from the Yong Loo Lin School of Medicine, National University of Singapore in 2010 and subsequently pursued her postgraduate training in Internal Medicine with SingHealth. She obtained her membership to the Royal College of Physicians, United Kingdom, in 2013. Dr Lam completed her Medical Oncology Senior Residency training at the National Cancer Centre Singapore in 2016.

Kai-Keen Shiu

Consultant Oncologist | United Kingdom

Dr. Shiu is a Consultant in the Gastrointestinal Oncology Unit at University College London Hospital NHS Foundation Trust and Honorary Associate Professor at the UCL Cancer Institute. His research interests include immunotherapy for GI malignancies and Cancer of Unknown Primary, as well as the development of novel cancer clinical trial designs. He is the Principal Investigator of the UCL/UCLH Gastrointestinal Cancer Translational Research Biobank and member of ASCO, ESMO and the Chair of the Association of Cancer Physicians New Consultant Group.

Lindsey Oudijk

Pathologist | Netherlands

Dr. Lindsey Oudijk is a staff pathologist at Erasmus University Medical Center in Rotterdam, the Netherlands, specialized in gastro-intestinal and endocrine pathology. Her interest lies in biomarker development/ detection in upper GI (gastro-oesophageal) cancers.

Mofazzel Hossain

Chief Consultant Medical Oncologist | Bangladesh

Prof. Dr. Md. Mofazzel Hossain has been serving as Chief Consultant Medical Oncologist, BRB Hospitals LTD, Dhaka, Bangladesh since 2018. After his retirement from Army Prof. Mofazzel had been working as Head of the Department of Oncology, Bangladesh Medical College, Dhaka from March 2003 till his joining as Chief Consultant Medical Oncologist on 01 July 2011, a fulltime dedicated job, in Lab Aid Specialized Hospital, Dhaka, the busiest and most reputed hospital in Dhaka for its efficient multidisciplinary services, where he served upto 25-06-2018. He is a member of ASCO, ESMO for long time and life member of APB (Association of Physicians of Bangladesh).He is also a member of SSO(Singapore Society of Singapore).

Pierce Chow

Senior Consultant | Singapore

Prof. Pierce Chow is a senior consultant and Co-Director (Surgical) of the Comprehensive Liver Cancer Clinic at the National Cancer Centre Singapore, Senior Consultant Surgeon in HPB and Transplant Surgery at the Singapore General Hospital and Professor and Course Director at Duke-NUS Medical School Singapore. In addition to managing a busy HPB surgical oncology service, Prof. Chow has researched extensively on hepatocellular carcinoma (HCC). He leads collaborative research on the genomic heterogeneity of HCC and applications in precision medicine.

Qian Wang

Clinical Fellow of Medical Oncology | China

Dr. Qian is an Associate Professor at Cancer Hospital of China Medical University/Liaoning Cancer Hospital and Institute, Shenyang, China. She is also Clinical Fellow of Medical Oncology at National Cancer Center Singapore.

Raghav Sundar

Medical Oncologist | Singapore

Dr Raghav Sundar is a Consultant Medical Oncologist specialising in Gastrointestinal cancers and early phase clinical trials. His clinical interest is in gastrointestinal cancers. His research interest lies in early phase drug development, immunotherapy, DNA damage repair, and chemotherapy-induced neuropathy. He has published in high impact peer-reviewed journals including Cancer Discovery and Clinical Cancer Research and designs clinical trials for novel cancer drugs.

Richard Finn

Medical Oncologist | USA

Dr. Finn is a Professor of Clinical Medicine in the Division of Hematology/ Oncology at the UCLA David Geffen School of Medicine and Director of the Signal Transduction Program in the Jonsson Comprehensive Cancer Center at UCLA. His research interests lie in the development of molecular targeted agents and biomarkers in liver cancer and breast cancer. Dr Finn has served as principal and sub-investigator in trials exploring the use of targeted therapies in breast and hepatocellular cancers. He has a particular interest in identifying predictive markers of response to novel therapeutics

Shaheenah Dawood

Medical Oncologist | United Arab Emirates

Dr Shaheenah Dawood is a Consultant Medical Oncologist and Professor in Clinical Oncology in the United Arab Emirates. She was trained in medical oncology at McGill University Hospitals in Canada and subspecialized in breast cancer management at MD Anderson Cancer Center. During her training, she was awarded multiple scholar training awards besides ASCO merit awards. Dr Shaheenah has served as an editorial fellow at the New England Journal of Medicine and has an MPH from the Harvard School of Public Health. She has over 100 papers to her credit including 50 peer review original articles, 30 review articles, and 12 book chapters. Having served as a reviewer for multiple journals including the Journal of Clinical Oncology she is currently leading the oncology clinical trials program at Mediclinic City Hospital, Dubai. She also serves as President of Excellence in Oncology Care (EIOC) annual congress held in Dubai and is Co-Chair of the Asia Pacific Breast Cancer Summit (APBCS), Asia Pacific Gastrointestinal Cancer Summit (APGCS) ,the international BRCA forum (iBRCAf) and Young Women Forum (YWF) from over a decade.

Shailesh Shrikhande

Medical Oncologist | India

Professor Shailesh V. Shrikhande is a Gastrointestinal Cancer Surgeon from Mumbai, India. He has over two decades of experience with special interest in Pancreatic Cancer surgery. He is the Deputy Director of Tata Memorial Hospital in Mumbai and also the Head of Division Cancer Surgery and Chief of GI and HPB Surgery. He is the President of the Indian Chapter of IHPBA 2019 – 2021 and Scientific Committee Chair of IHPBA 2019-2021.

Sherilyn Liew

Senior Resident | Singapore

Senior Resident - National Cancer Centre Singapore

Stephen L. Chan

Medical Oncologist | Hong Kong

Dr. Stephen L. Chan is the Associate Clinical Professor of the Department of Clinical Oncology in the Chinese University of Hong Kong. He graduated from the University of Hong Kong in 2000 and obtained specialist qualification in Medical Oncology in 2007. He has been awarded the Gold Medal Prize for Dissertation in 2007 and Young Investigator award in 2008 by the Hong Kong College of Physician. His main research area is on clinical and traditional researches for gastrointestinal cancers, especially hepatobiliary and pancreatic cancers.

Syed Akram Hussain

Professor and Senior Consultant, Oncology Dept. Square Hospitals Limited | Bangladesh

Dr. Sayed Md. Akram Hussain graduated MBBS from Dhaka University, Bangladesh (studied with merit scholarship from Bangladesh Govt.) on year 1990. Later on 2000, he achieved residency in Radiation Oncology at National Institute of Cancer Research and Hospital Fellow (Radiation Oncology) of Bangladesh College of Physicians and Surgeons (BCPS). He accomplished Masteras of Public Health (Epidemiology), from New Castle University, USA on year 2005 and Mastera of Public Health (Clinical Epidemiology), from Atish Dipankor Science & Technology University, Dhaka, Bangladesh on year 2010. He also took Fellow of College Physicians and Surgeons of Glasgow from UK on year 2010 & Fellow of College Physicians of Edinburgh, UK on year 2011. He has expertise on IMRT, IGRT, Gating System, CT, MRI Simulation and Brach therapy. He is currently working as Professor and Head of the Department of Oncology at North East Medical College.

Toh Han Chong

Deputy Medical Director | Singapore

Dr Toh is Senior Consultant and Deputy Chief Executive Officer (Strategic Partnerships), Division of Medical Oncology, National Cancer Centre Singapore. He graduated from the University of London, UK with an intercalated Bachelor of Science in ‘Infection and Immunity’ from St Mary’s Hospital Medical School and qualified as a medical doctor from University of Cambridge, UK. Dr Toh obtained his Fellowship of the Royal College of Physicians in 2003. He received his medical oncology fellowship training at the Singapore General Hospital, Massachusetts General Hospital, Harvard Medical School, Boston USA, and at the Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas, USA. He is also an alumni at the Harvard Business School General Management Program. Dr Toh is a recipient of the National Senior Clinician Scientist Award in 2017 and National Medical Excellence Award (NMEA) in 2018 for his pioneering work in cell and immunotherapy for cancer. He leads the NMRC LCG VICTORY (Virus-Induced Cancers Translational Oncology and immunologY) grant. As an Associate Professor and College Master at the Duke-NUS Graduate Medical School, Dr Toh is actively involved in medical education and training. He is the founding Chairman of the Singapore Society of Oncology Cancer Immunotherapy Consortium, co-founder of the Asia Pacific Gastroenterology Cancer Summit (APGCS), and faculty in the Cancer Immunology for the European Society of Medical Oncology (ESMO). Dr Toh has published over 132 peer review journal papers to date.

Wang Weining

Senior Resident, Medical Oncology | Singapore

Dr. Wang is the Senior Resident, Medical Oncology at National Cancer Centre Singapore.

Wong Kar Yong

Head of Service (Colorectal Surgery), Senior Consultant | Singapore

Dr. Wong Kar Yong is a General Surgeon currently practising in Tan Tock Seng Hospital. His specialty interest is in colorectal cancer surgery, especially with the use of minimal invasive and robotic surgery. Dr. Wong specialises in minimal invasive colorectal cancer surgery. He is proficient in advanced colorectal procedures such as extended lymph node dissection surgery in advanced colorectal cancer, transanal endoscopic microsurgery and colonic stenting. Dr. Wong is currently a Senior Consultant Surgeon at Tan Tock Seng Hospital.

Yong Wei Peng

Senior Consultant, Department of Haematology-Oncology | Singapore

Dr Yong Wei Peng obtained his medical degree and postgraduate training in University of Aberdeen, Scotland. After completing an oncology fellowship at the National University Hospital, he was awarded the A*star international clinical pharmacology fellowship at the University of Chicago. Upon his return to Singapore, he was awarded a three-year Investigatorship Award under the Clinician Scientist Award to further his research into personalized therapy. Dr Yong leads the therapeutic arm (NUH module) of the Singapore Gastric Cancer Consortium. The consortium received the prestigious five-year Translational Clinical Research grant in 2007. He is also the Chairman of the National Healthcare Group Domain-Specific Ethics Review Board. His clinical interest is in gastrointestinal cancers and his research interests are pharmacogenetics and epigenetics in cancer.

Zev Wainberg

Gastrointestinal Medical Oncologist | USA

Dr. Zev Wainberg is the Professor of Medicine at UCLA and co-director of the UCLA GI Oncology Program. He was trained in medical oncology and hematology at UCLA. He completed his residency training at Albert Einstein College of Medicine and received his MD from the Sackler School of Medicine, New York Program at Tel Aviv University. His research involves a variety of clinical trials in multiple gastrointestinal cancers including pancreas, colon, gastric and esophageal. Dr. Wainberg's laboratory based research efforts involve the testing of novel therapeutics against all gastrointestinal cancers. Currently, he is the recipient of several grants focused on the targeting of cancer stem cells and in molecular classification of GI cancers.